Argus is StockTitan’s real-time momentum scanner, and it watches every stock on Nasdaq, NYSE and NYSE American, mega caps and penny stocks alike, catching sharp price moves and volume surges as they happen between the 4:00 AM premarket open and the 8:00 PM after-hours close.
Each alert puts the move next to any news or SEC filing that may explain it, so you can see why a stock is moving without hunting for the headline.
No account and no card are needed to watch the alerts with a 15-minute delay, and a Free account at no cost gets you the news and SEC filings feeds after 1 minute. Silver shows the alerts after 1 minute and lets you pick your strategies, while Gold and Platinum instead show every alert in real time, with filters for price, float, market cap, volume or news that you can save as your own presets.
Info: Show only stocks with recent news events. Badge Visibility: Impact scores (1-5) indicate the potential market influence; Sentiment scores (1-5) the overall tone. Toggle these badges on or off.
News Time Frame (both)
h
m
Show news from the last time period (0 = max 48h)
Badge Visibility
Movement Filter
Filter by direction and movement magnitude. Select gainers/losers and define price-change ranges.
Filter accessLocked
News windows, price, float, market cap and volume rules unlock with Gold — or go all-in with Platinum.
Current session: alerts for each stock during pre-market, regular hours, or after-hours, whichever is running. Today: alerts across all market sessions today. This counts scanner alerts, including those you did not receive as notifications.
Highly Restrictive: Using both today and session filters may severely limit results. Consider using only one.
Session (min)(alerts)
-
Session (max)(alerts)
Today (min)(alerts)
-
Today (max)(alerts)
Price Filter
Specify a stock price range to narrow results. Ideal for finding segments like penny stocks.
Filter accessLocked
News windows, price, float, market cap and volume rules unlock with Gold — or go all-in with Platinum.
Info:Volume reads the day's trading in the unit you pick: shares, or the money those shares are worth at the current price. Rel.Vol M compares today’s cumulative volume with the median at the same time of day over the 20-session profile, or with the 20-day average full-day volume when that profile is unavailable. 5m RVol divides the window’s shares by the 20-day average daily volume divided by 78; it has no time-of-day adjustment. 5m Traded $ values the window’s shares at the current price. These displayed values are separate from the Volume Spike trigger calculation.
Volume Unit (both)
Shares is active. Enter a traded $ amount to replace it.
Volume (min)(both)shares
-
Volume (max)(both)shares
Traded $ (min)(both)$
-
Traded $ (max)(both)$
Rel.Vol M (min)(both)x
-
Rel.Vol M (max)(both)x
5m RVol (min)(alerts)x
-
5m RVol (max)(alerts)x
5m Traded $ (min)(alerts)$
-
5m Traded $ (max)(alerts)$
Alerts
Alerts on stocks making big price moves, sudden five-minute swings or unusual trading volume, with the latest related news when there is any.
Silence Therapeutics plc (SLN) is trading on its agreement to be acquired by Merck KGaA, Darmstadt, Germany, for $20 in cash per ADS. The deal values Silence’s equity at approximately $1.3 billion and remains subject to approvals and other closing conditions.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
SCWorx (WORX) announced a new agreement to provide healthcare supply-chain data management services to a healthcare system, but disclosed no contract value or expected revenue contribution.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Shares are trading on Disc Medicine (NASDAQ: IRON)’s announcement that bitopertin met all primary and secondary endpoints in the pivotal Phase 3 APOLLO trial, with a 41.4% reduction in whole-blood metal-free PPIX and 12.2 additional hours of average monthly pain-free time in light.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Atlantic American Corporation (AAME)’s amended annual report discloses 2025 revenue of $210.4 million and net income of $6.0 million, but also says the company expects a Nasdaq staff delisting determination and that the amendment otherwise does not update the original report.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
J-Star Holding Co., Ltd. (YMAT) said it is negotiating to acquire a Greater Houston manufacturing facility for planned U.S. drone-frame production; the acquisition remains under negotiation.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Exyn Technologies (EXYN) said it joined MAP-POD, a project selected for award negotiations under the Department of Energy’s Mine of the Future Initiative, but the $29.5 million covers 17 projects, with no Exyn-specific award amount stated.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
3 E Network Technology Group (MASK) is trading on its announcement today that subsidiary Aurora Core Technology Oy signed a 9 MVA grid-connection agreement for its planned Finnish AI compute center, with full-capacity energization expected in 2027.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Cleveland-Cliffs Inc. (CLF) is trading on its third-quarter 2026 results, which returned the company to profitability and lifted adjusted EBITDA above guidance. An 8-K filed October 19 also reported fourth-quarter and 2027 adjusted EBITDA expectations.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
INLIF Limited (INLF) shares are trading on the company’s announcement of a US$3.75 million registered direct offering of ordinary shares and warrants, expected to close on or about October 20, subject to customary conditions.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
EyePoint, Inc. shares are trading on the company’s announcement that its Phase 3 LUCIA trial of DURAVYU in wet AMD missed its primary endpoint; the earlier LUGANO trial also missed that endpoint in its full dataset.
EyePoint also approved ending the pivotal wet AMD trials early, cutting approximately 53% of its workforce, and prioritizing DURAVYU development for diabetic macular edema.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Rubico Inc. (RUBI) disclosed a convertible-note and warrant financing on October 19, with $8,500,000 in gross proceeds from the initial closing and terms that can result in additional shares; the disclosure timing does not establish whether it preceded the start of today’s decline.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Baird Medical (BDMD) announced additional device registrations in Vietnam and preliminary approval in Egypt for its microwave-ablation technology, but the update describes regulatory progress rather than adverse news.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Pomdoctor Limited (POM) announced it will end its ADR program, exchange ADSs for listed Class A ordinary shares, and consolidate ordinary shares 10-for-1; the announcement does not specify an economic loss to holders.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
Read the Argus momentum scanner guide for scanner specifications, alert strategies, market coverage and frequently asked questions.
Argus provides market data and information only. Nothing in this service constitutes investment advice, trading recommendations, or guidance about buying, selling, or holding any security.
Free
Silver
Gold
Platinum
Silence Therapeutics plc (SLN) is trading on its agreement to be acquired by Merck KGaA, Darmstadt, Germany, for$20 in cash per ADS. The deal values Silence’s equity at approximately $1.3 billion and remains subject to approvals and other closing conditions.
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.